Biosyent inc
WebBioSyent, Inc. is a specialty pharmaceutical company, which engages in the development of pharmaceutical and healthcare products. Its products include Cathejell Jelly, FeraMAX Pd Therapeutic 150 ... WebMar 27, 2024 · BioSyent's low three-year median payout ratio of 9.0% (implying that the company keeps91% of its income) should mean that the company is retaining most of its …
Biosyent inc
Did you know?
WebFeb 3, 2015 · TORONTO, ONTARIO--(Marketwired - Feb 3, 2015) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) today announced that its subsidiary BioSyent Pharma Inc. has commenced the Canadian launch of the Aguettant System® for pre-filled syringes (PFS), a new urgent care product for use in hospitals and acute care settings. WebMar 31, 2016 · View Full Report Card. Fawn Creek Township is located in Kansas with a population of 1,618. Fawn Creek Township is in Montgomery County. Living in Fawn …
WebApr 6, 2024 · A high-level overview of BioSyent Inc. (BIOYF) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
WebApr 14, 2024 · Local SEO Guide, an SEO agency, was never located in Kansas, but Google My Business believes the Pleasanton, CA company has been located in Fawn Creek … WebIn market activity today, shares of Biosyent Inc opened at $7.50 and closed at $7.25. Intraday prices ranged from a low of $7.21 to a high of $7.50. The price shrank -4.61 percent from the ...
WebApr 9, 2024 · The company sells its products through wholesalers and retail pharmacy chains. The company was formerly known as Hedley Technologies Inc. and changed its name to BioSyent Inc. in June 2006 to reflect its forward focus on the pharmaceutical market. BioSyent Inc. was incorporated in 2006 and is headquartered in Mississauga, …
WebBioSyent Announces Grant of Restricted Share Units. MISSISSAUGA, Ontario, March 31, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent” or the “Company”, TSX … chronic condition health home iowaWebMar 9, 2024 · MISSISSAUGA, Ontario, March 09, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three months and full ... chronic compressive myelopathy icd 10WebBioSyent Inc. BioSyent, Inc. is a specialty pharmaceutical company, which engages in the development of pharmaceutical and healthcare products. chronic compression deformity l1WebMar 14, 2024 · Get the latest stock price for BioSyent Inc. (RX), plus the latest news, recent trades, charting, insider activity, and analyst ratings. chronic compression deformity of t12WebFind the latest BioSyent Inc. (RX.V) stock quote, history, news and other vital information to help you with your stock trading and investing. chronic condition improvement planWebDec 23, 2004 · Biosyent Inc has listed on the Toronto Venture Exchange (TSX-V) under the ticker RX. Trading volume was 5,300 on 11 total trades, with an average volume of 5,783 over 5 days. chronic complications of sickle cell diseaseWebBioSyent Inc. Mailing Address: 2476 Argentia Road Suite 402 Mississauga, Ontario L5N 6M1: Head Office Address: 2476 Argentia Road Suite 402 Mississauga, Ontario L5N 6M1: Contact Name: Robert March: Principal Regulator: Ontario: Business e-mail address: [email protected]: Short Form Prospectus Issuer: Yes: chronic concussion syndrome treatment